Dr. Jung Hyun Ahn has been the Chief Science Officer at PROTEINA since 2022, leading the company's new drug development and drug research initiatives. Dr. Ahn holds a Ph.D. in Genetics and Molecular Biology from Emory University and is an expert in the field of genetic research.